The purpose of this study was to assess whether simulation training can improve the clinician's ability to predict the effect of bivalirudin infusion.
Bivalirudin is a direct thrombin inhibitor. It is currently approved by the Food and Drug Administration only for short-term use during cardiac catheterisation in patients who are at risk of heparin-induced thrombocytopenia 1 . However, it is finding rare but increasing use in the critical care setting for patients who require anticoagulation for longer time periods as an alternative to heparin.
As a rarely used drug, clinical experience with its dosing is sparse. At the authors' institution, even advanced trainees have no experience with bivalirudin infusions until they rotate through the cardiac surgical intensive care unit (ICU), where use of bivalirudin is more frequent. Because of pronounced inter-individual variation 2 , predicting the individual patient's response to bivalirudin can be challenging, especially for inexperienced trainees.
Simulation training using software programs may prepare trainees before their first contact with patients. In intensive care medicine, software simulation programs are commonly employed to learn critical algorithmic tasks such as advanced cardiac life support 3, 4 or manual-cognitive skills such as bronchoscopy 5 .
The goal of the following study was to determine if simulation training could improve the ability of physicians to predict the effect of bivalirudin. One group of physicians had previous experience titrating bivalirudin infusions, the other did not. We compared the improvement in performance of both groups under the hypothesis that both groups would improve and that their level of performance would converge.
MATERIALS AND METHODS
The simulation training program was created using a previously existing database including all patients who received bivalirudin in the ICU after cardiac surgery with cardiopulmonary bypass at our institution (a large university medical centre) from 2002-2008. From the total database (263 patients), a random sample of 30 patients was selected. Parameters were retrieved electronically and by manual chart review, including the exact timing of changes in the bivalirudin infusion and the corresponding partial thromboplastin time (PTT) values that were obtained for clinical monitoring at that time. Laboratory data that may have implications in the assessment of the patients' coagulation, such as liver function tests and estimated glomerular filtration rate (indicator of renal elimination of bivalirudin), were included as well. For simulation training using this retrospective data, a graphical user interface was designed using Matlab ® (Mathworks, Natick, MA) displaying all pertinent patient data graphically and numerically including the infusion rate of bivalirudin preceding a certain time point. The program pauses just before each new PTT determination was actually performed in the patient. The user then enters his or her next guessed PTT by clicking into the display of previous PTT values using the mouse. Then the program displays the true PTT ( Figure 1 ). Subsequent laboratory and infusion data is then displayed up to the time point just before the next PTT was drawn, prompting the user for a new guess. One absolute guessing error (AGE) is calculated from the average of all PTT guessing errors (absolute value of guessed minus actual PTT) of one physician in one patient. Each physician repeats this process for the same sequence of 30 patients, leading to 30 AGE values per physician.
Institutional Review Board approval was obtained for the retrospective collection of patient data and for the simulation testing of six physicians from our institution who were categorised as having experience and six who had no experience with bivalirudin (Groups Exp and NoExp, respectively). Each physician completed a brief survey with the questions shown in Table 1 . For each of the 30 sequential patients, all AGE values within Groups Exp and NoExp were averaged to form two average AGE (AAGE) values. Thus, there were two AAGE values for each patient corresponding to the average performances of Groups Exp and NoExp, respectively. All AAGE were logtransformed to make their distributions normal, as determined by the Jarque-Bera test for normality.
Linear regression with a term for interaction where 'NoExp' was coded as '1' for physicians without experience and '0' otherwise. The term 'B3*patient_ number' indicates if changes in performance occur as training progresses from patient one to 30 and can be interpreted as a learning curve. The interaction term 'B4*NoExp*patient_number' would test for any difference in performance over the course of evaluating 30 patients between the two groups, i.e. it would test if the learning curve was significantly different in Groups Exp and NoExp.
As a second method of evaluation, the AAGE values were grouped into terciles corresponding to patients 1-10, 11-20 and 21-30. Two-way analysis of variance and a multiple comparison test with Bonferroni adjustment were applied to analyse the difference between the performance of Groups Exp and NoExp.
RESULTS
Six residents with no prior experience titrating bivalirudin (Group NoExp) and six ICU fellows and staff intensivists with 12 months or more experience (Group Exp) were recruited. Group NoExp was recruited via email solicitation to all junior residents of the anaesthesia residency program. Group Exp included the four fellows who had completed clinical rotations in the cardiac surgical ICU (there were no other residents or fellows available who were experienced with bivalirudin). In addition, two of five available staff intensivists participated. Their baseline characteristics were assessed with a brief survey ( Table 1) . Before simulation training began, the study staff briefly reviewed information available in the package insert of bivalirudin with members of Group NoExp. This included the dosing recommendations and the altered clearance in the setting of renal failure 1 .
All physicians completed the simulation for 30 patients within two hours, entering 813 guesses each. The median duration of bivalirudin infusion was 6.5 days (2.8-14.0 interquartile range), with a median interval between PTT laboratory data of 7.4 hours (5.3-10.8 interquartile range).
After each physician evaluated the same 30 patients in the same order, the AAGE values of Groups Exp and NoExp were determined and plotted as individual markers (Figure 2) . The linear regression model given in Equation 1 was fitted to the AAGE for Groups Exp and NoExp and is superimposed in Figure 2 . The coefficient B4, representing the interaction between the training status 'NoExp' and the term 'patient_ number', was significantly less than zero, indicating that the improvement in performance in Group NoExp was faster than in Group Exp (P=0.01). See Table 2 for regression results.
When dividing the results of the training sequence into terciles, Group Exp performed significantly better than Group NoExp in the first and second terciles but not in the final tercile (Figure 3 ). Average errors in Groups Exp and NoExp decreased from 9.4 and 11.7 seconds in the first tercile, to 8.2 and 8.4 seconds in the last tercile of patients, respectively.
DISCUSSION
This study involving simulation training of physicians yielded two principal findings. First, both inexperienced and experienced physicians improved Results are given as median with overall range. ICU=intensive care unit. log(average_absolute_guessing_error) =B1+B2*NoExp+B3*patient_number+ B4*NoExp*patient_number + residual_error their guessing performance in the course of training using the same randomised dataset. Second, while the experienced physicians performed significantly better than the inexperienced physicians initially, the performance of both groups converged by the end of the two-hour training session. Once the last tercile of training data was reached, both groups had improved and their performance was no longer significantly different. The presence of a learning curve for both physician groups was not unexpected given the efficient presentation of training data. Even for the experienced group, the 30-patient training sequence represented considerable additional training exposure. After all, the median number of patients managed by the experienced physicians prior to the study had only been 40 patients. In addition, in our simulation training, the graphic display of the patient's data provided a more comprehensive overview than is commonly available at our institution in the clinical setting; the norm being paper ICU flow sheets. This makes it likely that learning and pattern recognition would be acquired more rapidly than in clinical practice and would explain why even the experienced physicians showed a significant improvement.
Limitations of our study included the small number of physicians in Group Exp; only four fellows rotated through the cardiac surgical ICU on a yearly basis and the pool of available staff intensivists was small. Therefore, two staff intensivists were recruited into Group Exp to augment the four fellows. Also, the ability of both groups to retain the acquired know-ledge over a longer time period (i.e. months later) could not be tested and compared because the fellows left the training program and hospital after completion of the fellowship year.
Medical simulation training has been shown to improve performance in simulation settings 6 , in actual clinical situations anecdotally 7 and in clinical settings 8, 9 . Therefore, gaining an understanding of patients' responses to bivalirudin through intense simulation training may enable clinicians to more safely titrate bivalirudin in clinical practice. Since patients undergoing cardiac surgery with cardiopulmonary bypass may have a different response to bivalirudin than other patient populations, it is appropriate to undergo simulation training with data originating from the same clinical setting, as we have done in this study.
Due to increasingly comprehensive electronic patient data collection, databases for simulation Note that B4 is the coefficient for the interaction term representing the difference in the learning curve between experienced and inexperienced physicians. Figure 3 : Average absolute guessing errors of the inexperienced (NoExp) physicians were significantly greater than of the experienced (Exp) physicians for the first and second terciles (* indicates P <0.05). However, after the physicians had trained by evaluating the first 20 patients, there was no significant difference in performance in the last tercile.
should become more readily available for every clinical scenario and facilitate the type of simulation training we demonstrated in this study. Use of actual patient data instead of artificial or synthetic data for training may enable trainees to build an unbiased mental model of the patient and may augment more traditional methods of teaching. Ultimately, simulation training using original patient data may lead to more accurate titration of medication in the clinical setting and increased patient safety.
